Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2023-03-03 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
益丰药房关于向不特定对象发行可转换公司债券申请获得上海证券交易所受理的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the acceptance of its application by the Shanghai Stock Exchange for the issuance of convertible bonds to unspecified investors. It mentions regulatory review and approval processes by the stock exchange and the China Securities Regulatory Commission. The document is short (627 characters) and serves as a notification of the acceptance of the application and the ongoing review process, rather than the issuance of the bonds or detailed financial data. This fits the category of a Capital/Financing Update (CAP), as it relates to company fundraising activities and capital structure changes.
2023-03-03 Chinese
中信证券股份有限公司关于益丰大药房连锁股份有限公司向不特定对象发行可转换公司债券之发行保荐书
Capital/Financing Update Classification · 95% confidence The document is titled as an "发行保荐书" (Issuance Sponsorship Letter) issued by 中信证券股份有限公司 (CITIC Securities Co., Ltd.) regarding the issuance of convertible corporate bonds by 益丰大药房连锁股份有限公司 (Yifeng Pharmacy Chain Co., Ltd.). It contains detailed information about the bond issuance, including legal compliance, underwriting, due diligence, financial conditions, shareholder information, and regulatory adherence. The document is a formal sponsorship letter supporting the issuance of convertible bonds to unspecified investors, which is a capital raising activity. It is not a financial report like an annual or interim report, nor is it a regulatory filing or announcement of voting results. It is a detailed document related to capital/financing update and issuance. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the full sponsorship letter, not just an announcement or summary.
2023-03-03 Chinese
中信证券股份有限公司关于益丰大药房连锁股份有限公司向不特定对象发行可转换公司债券之上市保荐书
Capital/Financing Update Classification · 95% confidence The document is titled as a "上市保荐书" (Listing Sponsorship Letter) issued by 中信证券股份有限公司 (CITIC Securities Co., Ltd.) for 益丰大药房连锁股份有限公司's issuance of convertible bonds to unspecified investors. It contains detailed information about the issuer, business operations, financial data, risk factors, and terms related to the convertible bond issuance. The document is a comprehensive sponsorship and underwriting report related to a capital market transaction, specifically the issuance of convertible bonds. It is not an earnings release, annual report, or management discussion, nor is it a simple announcement or certification. It is a detailed capital/financing update document related to fundraising activities and capital structure changes. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and content confirm it is a full report, not just an announcement or notice.
2023-03-03 Chinese
天健会计师事务所(特殊普通合伙)关于益丰大药房连锁股份有限公司向不特定对象发行可转换公司债券的财务报告及审计报告
Annual Report Classification · 95% confidence The document is a detailed financial statement note for the fiscal year 2019 of 益丰大药房连锁股份有限公司. It includes extensive accounting policies, financial measurement bases, asset classifications, and other detailed financial disclosures. The length is substantial (15,000 characters) and it contains substantive financial data and explanations, not merely an announcement or summary. The content aligns with what is typically found in an Annual Report or a comprehensive financial report. Given the detailed nature and the inclusion of financial statement notes, this document fits best under the Annual Report (10-K) category rather than a shorter interim report or a regulatory filing. There is no indication that this is a certification, announcement, or presentation. Therefore, the classification is Annual Report (10-K). FY 2019
2023-03-03 Chinese
益丰药房高级管理人员集中竞价减持股份计划公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding a shareholding reduction plan by senior management personnel of the company. It details the number of shares held by specific executives, the planned reduction amounts, timing, and reasons for the reduction. It does not contain financial statements, earnings data, or detailed management discussion. The content fits the definition of a 'Director's Dealing' report, which covers personal share transactions by company directors and executives. The document length is short and focused solely on insider share sales, confirming it is not a full financial report or other type of filing.
2023-02-24 Chinese
益丰药房第四届董事会第二十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at a board meeting of 益丰大药房连锁股份有限公司 on February 23, 2023. It includes multiple agenda items related to the issuance of convertible bonds to unspecified objects, amendments to company bylaws, and authorization for the board to handle bond issuance matters. The document contains voting results for each resolution and mentions that some matters require shareholder approval. The content focuses on board decisions and approvals rather than full financial statements or earnings data. There is no indication that this is a full annual or interim report, audit report, or earnings release. The document is not a call transcript or investor presentation. It is not a proxy solicitation or voting results declaration. The primary focus is on board meeting resolutions and management decisions. Therefore, the document best fits the category of Board/Management Information (MANG). The document length (8785 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2023-02-23 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.